Farms.com Home   Ag Industry News

Cargill Closes High River Beef Plant

Cargill Closes High River Beef Plant

By Amanda Brodhagen, Farms.com

Substantial flooding in High River, part of Southern Alberta has prompted the closure of one of the largest beef plants in Western Canada.  

Cargill’s High River Plant will remain closed due to washed away roads and surrounding infrastructure that’s been impacted due to floods. The plant hasn’t been directly hit by flooding, but many of its 2,000 employee’s homes are directly affected.

A company spokesperson said that its primary focus is keeping employees safe and allowing them to attend to personal situations. Additionally, the disruption of access to fresh water would impact the company’s ability to operate. On a normal day the plant would process about 4,500 head of cattle per day.

Cargill shut down its operations on Friday and will continue to assess the situation on a daily basis. The plant cafeteria is currently being used by emergency crews. Alberta is home to 40 percent of Canada’s beef cattle herds.
 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.